Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2009 2
2010 1
2012 2
2013 2
2014 4
2015 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A metabolic biosignature of early response to anti-tuberculosis treatment.
Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT. Mahapatra S, et al. Among authors: gitta p. BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53. BMC Infect Dis. 2014. PMID: 24484441 Free PMC article.
What is the most reliable solid culture medium for tuberculosis treatment trials?
Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD. Joloba ML, et al. Among authors: gitta p. Tuberculosis (Edinb). 2014 May;94(3):311-6. doi: 10.1016/j.tube.2014.03.002. Epub 2014 Mar 19. Tuberculosis (Edinb). 2014. PMID: 24698569
How we determined the most reliable solid medium for studying treatment of tuberculosis.
Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV. Heilig CM, et al. Among authors: gitta p. Tuberculosis (Edinb). 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006. Epub 2014 Mar 4. Tuberculosis (Edinb). 2014. PMID: 24661816 Free PMC article.
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, Okwera A, Mugerwa RD, Alcaneses MR, Quelapio MI, Tupasi TE, Horter L, Debanne SM, Eisenach KD, Boom WH. Johnson JL, et al. Among authors: gitta p. Am J Respir Crit Care Med. 2009 Sep 15;180(6):558-63. doi: 10.1164/rccm.200904-0536OC. Epub 2009 Jun 19. Am J Respir Crit Care Med. 2009. PMID: 19542476 Free PMC article. Clinical Trial.
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, Yoon C, Kato-Maeda M, Nahid P; Tuberculosis Trials Consortium. Jayakumar A, et al. Among authors: gitta p. Tuberculosis (Edinb). 2015 Jul;95(4):415-20. doi: 10.1016/j.tube.2015.04.011. Epub 2015 May 9. Tuberculosis (Edinb). 2015. PMID: 26022314 Free PMC article. Clinical Trial.
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium. Dorman SE, et al. Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30. Am J Respir Crit Care Med. 2009. PMID: 19406981 Clinical Trial.
13 results